Hyloris Pharmaceuticals SaEURONEXT: HYL

Board of Directors appoints Stijn Van Rompay as CEO

· Issued by Hyloris Pharmaceuticals Sa

19 Nov 2025 07:46 CET

Subscribe
Issuer

HYLORIS PHARMACEUTICALS SA

pr-hyloris-governance-update.pdf

Source

HYLORIS

Provider

Euronext

Company Name

HYLORIS

ISIN

BE0974363955

Symbol

HYL

Market

Euronext